18th Annual Clinical Trial Supply West Coast 2025

Developing best practices and incorporating novel technologies to meet the demands of a more complex, international clinical trial supply chain

9 - 10

September

2025
  • Burlingame, CA, USA
  • Complimentary
  • Why attend?
  • 2024 Agenda
  • Advisory Board
  • 2024 Speakers
  • Plan Your Visit
  • Event Gallery
  • 2024 Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Featured Speakers

Back

Gordon Chu​

Director of Investigations Branch, FDA

Gordon Chu is the Director of Investigations Branch at the Food and Drug Administration (FDA) Division of West Coast Imports (DWCI) within the Office of Enforcement and Import Operations (OEIO).

In this role, Mr. Chu develops, manages, and evaluates inspectional matters for DWCI covering all FDA import activities associated with air and sea port operations in the States of Hawaii, California, Nevada, Oregon, and Washington. The Investigations Branch handles: importer inspection, import sample collection, field examination, entry review, investigation, and inspection of imported FDA regulated products. He works cooperatively and collaborates with Federal, State, and local agencies to ensure appropriate consumer protection.

Mr. Chu began his FDA career in 2002 as a Consumer Safety Officer (CSO). As a CSO, he conducted domestic food inspection, consumer compliant investigation, recall traceback investigation, and inspection of imported FDA regulated products. In 2010, he became a Supervisor Consumer Safety Officer (SCSO). As a supervisor, he had the opportunity to manage an Import Field Operation Team, an FDA team in the Centralized Examination Stations (CES), and the Los Angeles International Mail Facility. Mr. Chu was also the Import Program Manager (IPM) for the FDA Los Angeles District. As the IPM, he is the District liaison to FDA Headquarter handling import related issues and concerns. Mr. Chu was selected to be the Director of Investigations Branch (DIB) for DWCI in June 2018.

Mr. Chu has served as a mentor for the Federal Executive Board in Los Angeles, CA. He also served on multiple FDA Headquarter working group and committee related to Food Safety Modernization Act (FSMA), import process improvement, strategic framework, rapid screening technology, and partnership agreements. He also been instrumental in enhancing FDA relationship with U.S. Customs and Border Protection (CBP) and other Partnering Government Agencies. Mr. Chu holds a Bachelor of Science in Applied Ecology from the University California of Irvine.

Next speaker
Back

Charisse Eary​

Executive Director, Head of Quality, Aligos Therapeutics

Next speaker
Back

Ryan Mills​

Senior Director, Head of Supply Chain, Denali Therapeutics

Ryan is a versatile, results-oriented Supply Chain professional with 15+ years experience across multiple industries and roles.

His top skills include: Supply Chain Strategy; Forecasting and Demand Management; Supply and Capacity Planning; Risk Management; Data Analytics; Business Process Design and Optimization; ERP Implementation; Team Leadership; Program and Project Management; Career Development

Next speaker
Back

Brittney Elko​

Senior Director, Technical Operations and Supply Chain, Aligos Therapeutics

Brittney is currently Senior Director, Technical Operations & Supply Chain at Aligos where she is responsible for the supply chain department and external vendors accountable for packaging, labeling and distribution of clinical trial materials to investigational sites.

Brittney has more than 15 years of experience working in both technical development and supply chain organizations in the consumer products and pharmaceutical/biotech industries.  Prior to Aligos, she was at Tricida, Intarcia, and Genentech where she managed all aspects of supplying 40+ clinical trials across the world in over 30 countries for thousands of patients. She also managed the commercial supply chain for the Clorox Disinfecting Wipes business, dealing with un-precedented demand changes through the H1N1 flu outbreak.

Next speaker
Back

Reena Patil​

Vice President, Chemistry, Manufacturing and Control (CMC) Strategy, Supply Chain Logistics and Project Management, Gritstone Bio Inc

Results-oriented, motivational strategic leader with extensive experience in developing, launching, and managing global projects. Adept at managing CMC activities from initial product development stages, supporting regulatory submissions, product launch, and ensuring stable commercial supply. Capacity for communication, collaboration, and leadership, establishing relationships with multidisciplinary teams internally and externally engaging business development partners and contract manufacturing sites for outsourced work to facilitate project goals.

Next speaker

    2024 Sponsors Include:

    Back

    Company Information

    PCI is a leading global CDMO, providing integrated end-to-end drug development, manufacturing and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of supply chain healthcare services.  With 30 sites across Australia, Canada, North America, the UK and Europe and over 4,300 dedicated employees, our mission is to bring life-changing therapies to patients. Leading technology and continued investment enable us to deliver development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.

    Company Website

    To learn more, please visit our website - http://pciservices.com/

    Next Sponsor
    Back

    Company Information

    The Inceptua Group Group is a dynamic, enterprising, and future-oriented service provider operating within the clinical trial and unlicensed medicines supply chain at an international level.

    Our multinational team provide connections to an extensive global network, offering our clients customized solutions ranging from strategic planning and sourcing, clinical manufacturing and global depot solutions, right through to early access to unlicensed medicines.

    We are committed to safety, and reliably supporting our clients every step of the way, leaving them safe in the knowledge that every potential obstacle has been considered, and every eventuality planned for.

    Our worldwide presence enables us to fulfil these services for the duration of trials, and our expert team work closely with our customers to ensure they receive full support throughout the lifecycle of their project.

    Company Website

    To learn more, please visit our website - http://www.inceptua.com/

    Next Sponsor
    Back

    Company Information

    Acnos Pharma is privately-owned, specialized pharmaceutical company operating globally in the clinical trial supply landscape. The headquarter is in Germany, Aachen. We offer flexible, cost efficient and quality sensitive customized solutions for individual trial requirements. We offer a broad range of clinical trial services supply chain management, clinical trial procurement and logistics.

    Th combination of passion and expertise leverages our global reach and maximizes customer satisfaction.

    Company Website

    To learn more, please visit our website - http://acnospharma.de/

    Next Sponsor
    Back

    Company Information

    Simply sourcing comparators – we offer a unique blend of small company flexibility and speed, backed with the large-scale buying power of the Orifarm Group, which is one of the largest pharmaceutical suppliers in Europe. With over €1.4B products sold in 2021 and more than 4,000 unique product lines sourced on a monthly basis, we have unparalleled access to “out of market” and manufacturer direct buying capability, both in the US and Europe.

    Company website: www.Orifarm-CTS.com

    Company Website

    To learn more, please visit our website - www.Orifarm-CTS.com

    Next Sponsor
    Back

    Company Information

    BMclinical, your global clinical trial supply partner. We offer worldwide commercial medicine supply, from analytical samples to bulk comparators, through to the supply of co-meds and pre-meds.  We can pack and label your IMP/commercial medicines from our GMP facility, where we also offer storage and distribution services. BMclinical is uniquely positioned to offer solutions for overage and unused clinical trial stock.

    Company Website

    To learn more, please visit our website - https://www.bmclinical.com

    Next Sponsor
    Back

    Company Information

    The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

    Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

    The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia.

    The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

    To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn or visit almacgroup.com.

    Company Website

    To learn more, please visit our website - https://www.almacgroup.com

    Next Sponsor
    Back

    Company Information

    Sharp is a global leader in clinical supply trial services and pharmaceutical packaging. For 70 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management.

    Company Website

    To learn more, please visit our website - http://www.sharpservices.com/

    Next Sponsor
    Back

    Company Information

    Since 1997, Clinigen has offered market-leading clinical trial supplies and biological sample management services to meet the most complex clinical supply challenges. Part of Clinigen Group’s global supply chain facility and depot network, we deliver tailored solutions for clients to ensure their clinical trials are a success, regardless of size or scope, from Phase I to Phase IV projects.

    Company Website

    To learn more, please visit our website - www.clinigencsm.com

    Next Sponsor
    Back

    Company Information

    Bionical Emas is a global Contract Research Organization (CRO) combining Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) bringing life-changing medicines to patients around the world. Our Clinical Trial Supply Division has a global vendor network of manufacturers, wholesaler distributors and optimized sourcing strategies to support your study. Whether you require products locally sourced in emerging markets and distributed directly to trial sites, global sourcing of high-value commercial drug products, or a demand-driven sourcing approach, we have the right solution for you.

    Company Website

    To learn more, please visit our website - http://www.bionicalemas.com

    Next Sponsor
    Back

    Company Information

    Mercalis has a suite of Clinical Trial Support services designed to provide time and cost efficiencies.

    RxStudy Card – Pharmacy provides commercially available medications and supplies through retail and specialty pharmacies. This supply strategy reduces supply process steps, requires less employee time, eliminates supply waste, and has fewer risks resulting in an 80% reduction in labor and a 50% reduction in costs.

    RxStudy Card – Provider provides reimbursement for site sourced and administered medication and is essential for studies requiring biologics and oncolytics, which are more frequently being sourced directly by a provider and not through a pharmacy.

    RxStudy Card – Procurement is an innovative GLOBAL clinical trial supply process that more efficiently provides commercially available medications and supplies. RxStudy Card – Procurement leverages “in country” sourcing and distribution, provides study teams and sites a simple online ordering experience for “just in time” “as needed” delivery, in quantities specific to each site and patients need with direct to site shipments and real time order and shipment status.

    Company Website

    To learn more, please visit our website - www.mercalis.com

    Next Sponsor
    Back

    Company Website

    To learn more, please visit our website - www.xerimis.com

    Next Sponsor

      Why attend?

      The 2025 programme of the Clinical Trial Supply West Coast will offer a fresh insight into the latest regulatory updates, global clinical supply chains, advanced technologies such as remote and hybrid trials, Artificial Intelligence, and more. With presentations, roundtables, and panel discussions on all the hottest industry trends and supply chain challenges, the 2-day event promises to provide the industry an unmissable opportunity to learn and network to help them succeed post-Covid.

      Get in touch now and secure your place!

      WHAT TO EXPECT FOR 2025?

      CTS West Coast is the meeting place for pharmaceutical and biotech experts to discuss key themes and opportunities to take control and optimize clinical supply chains.

      200+

      Attendees

      		25+

      Exhibitors

      		20+

      Speakers
      200+

      Attendees

      		25+

      Exhibitors
      20+

      Speakers

      Testimonials

      See What It's All About

      2024 Agenda

      • 17 Sep 2024
      • 18 Sep 2024
      Expand All

      Streams

      Stream one

      Clinical Trial Supply Operations

      Stream two

      Clinical Trial Supply Innovation & Technology

      7:45 AM

      Registration and refreshments

      8:25 AM

      Chair’s opening remarks

      Speakers

      Fiona Barry
      Editor-in-Chief and Director of PharmSource, GlobalData

      8:30 AM

      Opening Keynote: FDA importation overview and how to resolve issues with import entries being held for examination

      • Correcting common errors when importing drugs and devices into the United States.
      • How to communicate with FDA when your shipments are on hold?
      • Understanding the complexity of filing an FDA electronic entry.
      • Getting to know your FDA management staff when importing through the West Coast.

      Speakers

      Gordon Chu
      Director of Investigations Branch, FDA
      Sylvia Thomas
      Supervisory Consumer Safety Officer, Division of West Coast Import, FDA

      9 AM

      Aligning clinical supply strategies with sustainability goals

      Increasingly pharmaceutical companies are committing to reduce their carbon footprints in the execution of clinical trials. This session will cover how implementing innovative clinical trial supply technologies and sustainable processes can:

      • result in a more efficient use of human resources
      • reduce the number of logistical resources required
      • reduce waste
      • save money
      • lower the carbon footprint impact

      Speakers

      Robbie Hill
      Director, Business Development, Mercalis

      9:30 AM

      Optimizing cold chain logistics and improving green credentials to ensure the integrity of your products end-to-end

      • What are the latest technological advances and innovative systems adopted by the industry that can enhance cold chain distribution: What should be on your radar?
      • Hot topic in cold chain logistics: Sustainability - Aligning market growth with responsible practices to ensure businesses are making smarter decisions regarding the planet
      • Efficiently and effectively outsourcing management of temperature-sensitive materials to ensure your cold chain is never compromised
      • Expanding capacity on cold chain resources and enhancing end-to-end management to keep up with increasing demand and limited supplies

      Speakers

      Prashanth Chakravartula
      Senior Director, Warehouse & Logistics Bayer

      10 AM

      Fostering patient centricity and diversity equity & inclusion with your supply chain decisions

      • Discuss how patient insurance in the United States can impact a clinical trial patient’s experience in accessing therapies (i.e. SOC, comparators)
      • Discuss how companies are currently addressing improving Diversity Equity and Inclusion (DEI) in clinical trials and how appropriate medication access can support DEI
      • Supply chain considerations and optimizing the patient experience
      • FDA guidance on DEI plans for clinical trials

      Speakers

      Samit Bhatt
      Vice President, Clinical Trial Patient Solutions, Myonex

      10:30 AM

      Morning refreshments and networking

      11:15 AM

      Managing clinical supplies in a global study and the associated challenges with CMOs, CROs, suppliers, global regulatory directives, quality compliance, and risk

      Speakers

      Horacio Enriquez
      Director of Clinical Supplies and Supply Chain Management, Kezar Life Sciences

      11:45 AM

      Reserved for Inceptua

      12:15 PM

      Panel Discussion: How labelling technologies and strategies are redefining what is possible concerning fast and accurate clinical trial supply

      • Latest advancements with sourcing, labelling, and filing strategies for auxiliary medicinal product
      • Identifying the right packaging and storage solutions based on your bespoke needs to accelerate your drug supply
      • Improved expiry date predictions to avoid relabeling and reduce wastage
      • Recognizing different labelling requirements globally and how to ensure total adherence: What are the implications of the revised Annex 13 on labelling of IMPs
      • Enhancing label management with cloud-based technology to improve quality control and avoid
        unnecessary recalls

      Chair: Bei Li, Senior Director, Clinical Supply  Management, Gilead Sciences

      Speakers

      Bei Li
      Director, Clinical Supply Management
      Yuyi Shen
      Vice President, Technical Operations, Abcuro
      Ryan Mills
      Senior Director, Head of Supply Chain, Denali Therapeutics

      12:45 PM

      Lunch and networking

      2 PM

      A Holistic Approach to Supply Chain Planning for Clinical Trials

      • Why is supply chain planning important?
      • What are the foundational elements of successful supply chain planning for clinical trials?
      • What does the Clinical Planner need to account for within their plan?
      • What does the Clinical Planner need to effectively manage their plan?
      • Which business processes are required to ensure the Clinical Planner keeps their plan current and accurate?

      Speakers

      Ryan Mills
      Senior Director, Head of Supply Chain, Denali Therapeutics

      2:30 PM

      Reserved for event sponsor

      3 PM

      Optimizing inventory management to reduce inefficiencies in clinical supply chain

      • Ensuring readiness for unexpected disruptions: Contingency planning for failed batches to maintain supply chain resilience
      • Phase-appropriate inventory planning and how to best manage this alignment
      • Implementing the right tools and making data-driven decisions to modernize your inventory management strategy
      • Key considerations and solutions for improved tracking, managing, and purchasing supplies

      Speakers

      Umar Hayat
      Vice President, CMC and Supply Chain, Union Therapeutics

      3:30 PM

      Afternoon refreshments and networking

      4 PM

      How has your comparator sourcing strategy updated to keep up with changes in the industry and regulatory revisions?

      • Developing a risk-driven demand plan that can aptly accommodate changes in the quantity of comparators
      • Finding the right provider with a global comparator network who can provide timely and accurate product assessments and insight on how long they take to source
      • Single sourcing vs. decentralized sourcing to ease the demands on internal supply and logistics whilst being regulation compliant
      • Appropriately weighing risk vs reward with comparator sourcing to lead to successful outcomes

      Speakers

      Shubhra Kochar
      Global Strategy Lead Comparator Management, Clinical Supply Planning, Genentech

      4:30 PM

      Reserved for event sponsor

      5 PM

      Closing Panel Discussion: Levelling up vendor partnerships so that both sides win

      • Being more strategic with vendor partnerships and knowing what it means to be a true partner
      • Collaborating with all parts of the supply chain ecosystem to foster supplier relationships based on trust and mutual benefit
      • Why vendor flexibility and ability to customize is mission critical for sponsors
      • Ensuring alignment of incentives to avoid delays in supply shipments

      Chair: Paul Hingst, Associate Director, Crinetics

      Speakers

      Kalpesh Patel
      Associate Director, QA, BeiGene USA
      Tom Schiavon
      Manager, Clinical Systems and Technology, Insmed Incorporated
      Prashanth Chakravartula
      Senior Director, Warehouse & Logistics Bayer
      Paul Hingst
      Supply Chain Consultant, Crinetics Pharmaceuticals

      5:45 PM

      Chair’s closing remarks

      END OF DAY 1 AND NETWORKING DRINKS

      11:15 AM

      Innovative processes to propel clinical studies into the future

      • Transitioning from existing capabilities  and architecture to integrating powerful new solutions to optimize trial supply
      • Technology to determine next actions in preventing supply disruption, detect temperature excursions earlier and ensure patient safety
      • Obtaining increased data points to validate or adjust predetermined excursion criteria
      • Minimize discarding of potentially viable drug supply wi

      Speakers

      Victoria Vargo
      Director, Clinical Supply, Karyopharm Therapeutics

      11:45 AM

      Case Study: Optimizing clinical supply chain with advanced technology

      • Advanced technology in clinical supply chain
      • Case study – isolating objectives and delivering results through technology
      • Emerging technologies, risks and regulatory considerations – identifying trial supply use cases for AI/ML

       

      Speakers

      Cara Woodruff
      Director Product Management, IT Design and Development, IQVIA IRT

      12:15 PM

      Panel Discussion: Where does innovation fit in the highly regulated world of clinical trials?

      • Gaining enough traction for smallersoftware solutions companies with promising products to sustain their presence in the clinical ecosystem
      • How to best implement innovative vendor services to ensure they work within the pre-existing CRO universe
      • When CROs have too much power, how can we ensure innovation isn’t stifled?
      • What are the best ways to balance risk mitigation and innovation in a traditionally slow-paced industry?

      Chair: Mariam Iqbal, Director, Clinical Business Operations, Intercept Pharmaceuticals

       

      Speakers

      Louie Burks
      Associate Director Clinical Supply, Allakos
      Umar Hayat
      Vice President, CMC and Supply Chain, Union Therapeutics

      12:45 PM

      Lunch and networking

      2 PM

      Reducing the impact of increased data privacy requirements under data privacy laws on biotechs

      • Managing all considerable factors when it comes to data handling
      • Do the sites or vendors have a Data Privacy Officer or SOPs around data handling?
      • How to review data in an efficient way

      Speakers

      Ted Chun
      Director, Global Clinical Shared Services at Stryker Neurovascular

      2:30 PM

      Unlocking the Future: Real-World AI Integration in IRT

      • Introduction to AI in IRT - Understand the foundational concepts of machine learning, natural language processing, and data analytics.
      • Advanced Techniques with ChatGPT Plus - Explore pre-designed flows, customization, data visualization, and automation within IRT.
      • Next-Level AI Integration - Discover how AI can streamline core and auxiliary functions in clinical trials, from patient engagement to data analysis.
      • Enterprise Adoption of LLMs - Gain insights into strategic planning for large-scale AI adoption and future roadmaps for integrating AI into your enterprise.
        Senior Representative, Endpoint Clinical

      Speakers

      Chris Varner
      Senior Director of Solutions Consulting, Endpoint Clinical

      3 PM

      Transforming IRT implementation to improve the accuracy of CTS management: What’s new for 2024?

      • Capitalizing off the prominent role IRTs play in the decentralized approach of
        direct-to-patient drug deliveries Strategies for mid-study changes and how to best prepare for these
      • Achieving the greatest amount of visibility and control possible with IRT usage
      • Knowing when to justify the costs of customized IRT for the nature of your study

      Speakers

      Tom Schiavon
      Manager, Clinical Systems and Technology, Insmed Incorporated

      3:30 PM

      Afternoon refreshments and networking

      4 PM

      Looking at shipping and logistics from another angle: exploring watchouts & lessons learned in order to find an all-encompassing approach to proactively anticipate challenges

       

      • Explore best practice in close monitoring of transportation activities to guarantee timely supply delivery and minimize risk of loss or damage
      • Tackling inconsistent import and export regulations for transporting clinical supplies globally and optimizing your shipping process to ensure regulatory compliance
      • Effective strategies in mitigating shipping risks and reducing supply transportation costs

      Speakers

      Brittney Elko
      Senior Director, Technical Operations and Supply Chain, Aligos Therapeutics

      4:30 PM

      Reserved for event sponsor

      Streams

      Stream one

      Clinical Trial Supply Operations

      8:15 AM

      Registration and refreshments

      8:50 AM

      Chair’s opening remarks

      Speakers

      Fiona Barry
      Editor-in-Chief and Director of PharmSource, GlobalData

      9 AM

      Plan for success and prepare for adversity: How can we transform contingency planning to help anticipate unforeseen circumstances and budget appropriately

      • A macroeconomic perspective on clinical supplies – Managing supply distribution, resource shortages and transportation constraints to and in areas of conflict
      • Forecasting to optimize clinical trial supply management and better-informed decision making in dynamic trials
      • Key considerations for minimizing impact on patients during unprecedented situations
      • Collaborating cross-functionality to respond to trial disruptors to allow the trial to progress

      Speakers

      Kalpesh Patel
      Associate Director, QA, BeiGene USA

      9:30 AM

      Reserved for event sponsor

      10 AM

      How are you honing your data in the supply chain to make you more efficient and achieve actionable results?

      • Leveraging data to predictively build products in time to render your inventory better and less static
      • Rethinking your supply strategy through data-driven decision-making capabilities
      • How can we intelligently incorporate and optimize the true potential of the supply chain data?
      • Adapting to an age of decentralization with live and predictive analytics

      Speakers

      Charisse Eary
      Executive Director, Head of Quality, Aligos Therapeutics

      10:30 AM

      Morning refreshments and networking

      11:15 AM

      Panel Discussion: Benchmarking success and assessing efficacy in avoiding dangerous pitfalls in clinical trial supply

      • Take control of supply chain chaos: Preventing drug shortages through robust end-to-end visibility and streamlined workflows
      • Fulfilling moral obligations to do better by patients and win the war on counterfeit products
      • Why a secure network must remain mission critical: Prioritizing cybersecurity concerns throughout the supply chain to protect patients and healthcare providers
      • Maintaining a resilient supply chain strategy amid macroeconomic volatility

      Chair: Fiona Barry, Editor-in-Chief and Director of PharmSource, GlobalData

      Speakers

      Yuyi Shen
      Vice President, Technical Operations, Abcuro
      Charisse Eary
      Executive Director, Head of Quality, Aligos Therapeutics
      Supada Sritanyaratana
      Value Chain Portfolio Manager, Cell and Gene Therapy, Genentech
      Fiona Barry
      Editor-in-Chief and Director of PharmSource, GlobalData

      12 PM

      How supply chain sustainability will empower and optimize the way CTS strategies are planned to improve productivity and minimize costs

      • Future-proofing supply chains to endure greater long-term sustainability responsibilities
      • Sharing best practice for circular supply chain strategies and creating win-win business opportunities
      • Adhering to sustainable practices without adding cost and risk to the supply chain
      • Operational implications of striving for more sustainable shipping logistics

      Speakers

      Margaret Pese
      Associate Director, Supply Chain, 89Bio

      12:30 PM

      Session reserved for Fiona Barry, Editor-in-Chief and Director of PharmSource, GlobalData

      1 PM

      Networking and prize draw

      2:15 PM

      Speaker Hosted Round Tables

      Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others. Each roundtable lasts for 30minutes, delegates can select up to 2 roundtables.

      RT 1 Adapting to change in an evolving industry
      Prashanth Chakravartula, Senior Director, Warehouse & Logistics, Bayer

      RT 2 How does clinical trial supplies strategy differ between small studies, IST, R-CRC and large phase II and phase III?
      Amy Mou, Vendor Strategy Manager – FSP, Pfizer

      RT 3 Future-proofing your supply chain to maximize success, how are you doing it? RT 4
      The power of the patient voice and the patient-centric future of clinical trial supply

      RT 4 The power of the patient voice and the patient-centric future of clinical trial supply

      Speakers

      Amy Mou
      Vendor Strategy Manager – FSP, Pfizer
      Prashanth Chakravartula
      Senior Director, Warehouse & Logistics Bayer

      3:15 PM

      Chair’s closing remarks and end of conference

      2024 Speakers

      Select a speaker to learn more

      Back
      Gordon Chu
      Director of Investigations Branch, FDA

      Gordon Chu is the Director of Investigations Branch at the Food and Drug Administration (FDA) Division of West Coast Imports (DWCI) within the Office of Enforcement and Import Operations (OEIO).

      In this role, Mr. Chu develops, manages, and evaluates inspectional matters for DWCI covering all FDA import activities associated with air and sea port operations in the States of Hawaii, California, Nevada, Oregon, and Washington. The Investigations Branch handles: importer inspection, import sample collection, field examination, entry review, investigation, and inspection of imported FDA regulated products. He works cooperatively and collaborates with Federal, State, and local agencies to ensure appropriate consumer protection.

      Mr. Chu began his FDA career in 2002 as a Consumer Safety Officer (CSO). As a CSO, he conducted domestic food inspection, consumer compliant investigation, recall traceback investigation, and inspection of imported FDA regulated products. In 2010, he became a Supervisor Consumer Safety Officer (SCSO). As a supervisor, he had the opportunity to manage an Import Field Operation Team, an FDA team in the Centralized Examination Stations (CES), and the Los Angeles International Mail Facility. Mr. Chu was also the Import Program Manager (IPM) for the FDA Los Angeles District. As the IPM, he is the District liaison to FDA Headquarter handling import related issues and concerns. Mr. Chu was selected to be the Director of Investigations Branch (DIB) for DWCI in June 2018.

      Mr. Chu has served as a mentor for the Federal Executive Board in Los Angeles, CA. He also served on multiple FDA Headquarter working group and committee related to Food Safety Modernization Act (FSMA), import process improvement, strategic framework, rapid screening technology, and partnership agreements. He also been instrumental in enhancing FDA relationship with U.S. Customs and Border Protection (CBP) and other Partnering Government Agencies. Mr. Chu holds a Bachelor of Science in Applied Ecology from the University California of Irvine.

      Session Details:

      Opening Keynote: FDA importation overview and how to resolve issues with import entries being held for examination

      2024-09-17, 8:30 AM

      View In Agenda
      Next speaker
      Back
      Bei Li
      Director, Clinical Supply Management

      Bei Li has a Ph.D. in Pharmaceutical Chemistry with 10+ years of experience in pharmaceutical industry and hands-on experience in a wide spectrum of drug development stages ranging from discovery support, preformulation, to phase III formulation and process development. She has extensive experience in formulation development with expertise in a variety of dosage forms including solid and liquid oral formulation and parenteral (i.v., topical, subcutaneous, transdermal) formulations.

      She also has an-depth experience in GMP manufacturing of tablets, capsules, and iv solutions and managing contract research and manufacturing organizations, IND and CTA filings, and dealing with a wide range of drug delivery techniques including supersaturation, amorphous formulation, liposomes, and nanoparticles.

      Session Details:

      Panel Discussion: How labelling technologies and strategies are redefining what is possible concerning fast and accurate clinical trial supply

      2024-09-17, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Charisse Eary
      Executive Director, Head of Quality, Aligos Therapeutics

      Session Details:

      How are you honing your data in the supply chain to make you more efficient and achieve actionable results?

      2024-09-18, 10:00 AM

      Session Details:

      Panel Discussion: Benchmarking success and assessing efficacy in avoiding dangerous pitfalls in clinical trial supply

      2024-09-18, 11:15 AM

      View In Agenda
      Next speaker
      Back
      Ryan Mills
      Senior Director, Head of Supply Chain, Denali Therapeutics

      Ryan is a versatile, results-oriented Supply Chain professional with 15+ years experience across multiple industries and roles.

      His top skills include: Supply Chain Strategy; Forecasting and Demand Management; Supply and Capacity Planning; Risk Management; Data Analytics; Business Process Design and Optimization; ERP Implementation; Team Leadership; Program and Project Management; Career Development

      Session Details:

      Panel Discussion: How labelling technologies and strategies are redefining what is possible concerning fast and accurate clinical trial supply

      2024-09-17, 12:15 PM

      Session Details:

      A Holistic Approach to Supply Chain Planning for Clinical Trials

      2024-09-17, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Brittney Elko
      Senior Director, Technical Operations and Supply Chain, Aligos Therapeutics

      Brittney is currently Senior Director, Technical Operations & Supply Chain at Aligos where she is responsible for the supply chain department and external vendors accountable for packaging, labeling and distribution of clinical trial materials to investigational sites.

      Brittney has more than 15 years of experience working in both technical development and supply chain organizations in the consumer products and pharmaceutical/biotech industries.  Prior to Aligos, she was at Tricida, Intarcia, and Genentech where she managed all aspects of supplying 40+ clinical trials across the world in over 30 countries for thousands of patients. She also managed the commercial supply chain for the Clorox Disinfecting Wipes business, dealing with un-precedented demand changes through the H1N1 flu outbreak.

      Session Details:

      Looking at shipping and logistics from another angle: exploring watchouts & lessons learned in order to find an all-encompassing approach to proactively anticipate challenges

      2024-09-17, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Reena Patil
      Vice President, Chemistry, Manufacturing and Control (CMC) Strategy, Supply Chain Logistics and Project Management, Gritstone Bio Inc

      Results-oriented, motivational strategic leader with extensive experience in developing, launching, and managing global projects. Adept at managing CMC activities from initial product development stages, supporting regulatory submissions, product launch, and ensuring stable commercial supply. Capacity for communication, collaboration, and leadership, establishing relationships with multidisciplinary teams internally and externally engaging business development partners and contract manufacturing sites for outsourced work to facilitate project goals.

      Next speaker
      Back
      Shubhra Kochar
      Global Strategy Lead Comparator Management, Clinical Supply Planning, Genentech

      Session Details:

      How has your comparator sourcing strategy updated to keep up with changes in the industry and regulatory revisions?

      2024-09-17, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Ted Chun
      Director, Global Clinical Shared Services at Stryker Neurovascular

      Session Details:

      Reducing the impact of increased data privacy requirements under data privacy laws on biotechs

      2024-09-17, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Anthony L Colenburg Sr
      Senior Director & Site Head of Quality, Sutro Biopharma

      Dedicated Quality Assurance Leader who excels at phase-appropriate development/redevelopment, management and strengthening of an organization's Quality Culture to ensure a constant state of Inspection Preparedness & Readiness by:

      - establishing/re-aligning a current state feedback loop which utilizes close to real-time data, Quality metrics & Key Performance Indicators (KPI's);

      - creating robust assessment and evaluation programs that builds sensitivity, accountability, transparency and awareness collaboratively to constantly reduce Cost of Quality;

      - developing a strategic approach of continuous improvement to a Company's Quality Management System Elements which remain in a state of control.

      Next speaker
      Back
      Louie Burks
      Associate Director Clinical Supply, Allakos

      Experienced Project Manager in Product Development, Supply Chain, Business Operations and Logistics, and Change Management

      Session Details:

      Panel Discussion: Where does innovation fit in the highly regulated world of clinical trials?

      2024-09-17, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Margaret Pese
      Associate Director, Supply Chain, 89Bio

      High performing, excellence-driven, end-to-end Clinical Supply Chain Professional carrying over 20 years of industry experience in pharmaceuticals and biotechnology. Over 10 years of clinical and commercial supply chain experience. Proven success in leading study teams, including external partners, to target milestones on time and on budget. Highly skilled at supply and demand planning, developing distribution strategies, scenario planning and risk mitigation, troubleshooting, streamlining processes, saving on costs, and increasing the speed to clinics and to markets without compromising product quality.

      Session Details:

      How supply chain sustainability will empower and optimize the way CTS strategies are planned to improve productivity and minimize costs

      2024-09-18, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Paul Hingst
      Supply Chain Consultant, Crinetics Pharmaceuticals

      Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

      Session Details:

      Closing Panel Discussion: Levelling up vendor partnerships so that both sides win

      2024-09-17, 5:00 PM

      View In Agenda
      Next speaker
      Back
      Supada Sritanyaratana
      Value Chain Portfolio Manager, Cell and Gene Therapy, Genentech

      Supada manages a team of Product Leads to bring cell and gene therapies from acquisition to manufacturing readiness. They work on a growing portfolio of targeted and personalized medicines for oncology and ocular diseases that span from early clinical development to preparation for commercial launch.  Her responsibilities include due diligences, process development, system stakeholder, and contract manufacturer selection.

      Session Details:

      Panel Discussion: Benchmarking success and assessing efficacy in avoiding dangerous pitfalls in clinical trial supply

      2024-09-18, 11:15 AM

      View In Agenda
      Next speaker
      Back
      Tom Schiavon
      Manager, Clinical Systems and Technology, Insmed Incorporated

      Tom is currently serving as a Senior UAT Analyst for Bristol Myers Squibb. Most recently, he worked in clinical systems role for Ultragenyx Pharmaceutical, overseeing IRT, CTMS, eCOA, eConsent, CGM, and wearables systems and processes. Previously, he worked as an IRT senior project manager at Amgen, built and managed international technical support and data management teams, and worked as an IRT project manager, both at endpoint clinical. He has managed projects in the therapeutic areas of hematology & oncology, pain, bone, cardiovascular, and dermatology, from early-phase oncology through post-marketing studies. He graduated summa cum laude with a B.A in Philosophy and History from Florida Gulf Coast University, where he also earned an M.A. in English. He has published several articles on process improvement, change management, and making IRT concepts more accessible to sponsor study management personnel.

      Session Details:

      Transforming IRT implementation to improve the accuracy of CTS management: What’s new for 2024?

      2024-09-17, 3:00 PM

      Session Details:

      Closing Panel Discussion: Levelling up vendor partnerships so that both sides win

      2024-09-17, 5:00 PM

      View In Agenda
      Next speaker
      Back
      Umar Hayat
      Vice President, CMC and Supply Chain, Union Therapeutics

      Umar Hayat, Ph.D. is VP of CMC and Supply Chain at Union Therapeutics and has more than two decades of experience in pharmaceutical development, manufacturing and supply chain. He held senior level positions with Relypsa (acquired by Galenica for 1.52B US$), Anacor (acquired by Pfizer for 5.2B US$) and Transcept Pharmaceuticals (revers merger with Paratek). He played a pivotal role in the development and commercialization of Veltassa® (USA and EU), a treatment for hyperkalemia, Intermezzo® for MOTN insomnia, Kerydin® for onychomycosis, and Eucrisa® for atopic dermatitis. Dr. Hayat is managing partner of Revive Pharm USA. He is also a co-founder of U&D Pharma and working on Replyte Gel, a treatment for anogenital warts. Dr. Hayat received his Ph.D. in process engineering from INP-Toulouse, France and Post-Doctoral Fellowship from Ecole Polytechnique de Montreal, Canada. He received M.Sc. Chemistry degree from Punjab University, Institute of Chemistry

      Session Details:

      Panel Discussion: Where does innovation fit in the highly regulated world of clinical trials?

      2024-09-17, 12:15 PM

      Session Details:

      Optimizing inventory management to reduce inefficiencies in clinical supply chain

      2024-09-17, 3:00 PM

      View In Agenda
      Next speaker
      Back
      Cara Woodruff
      Director Product Management, IT Design and Development, IQVIA IRT

      A highly motivated, experienced IT Product Management professional with over 26 years of experience in the biopharmaceutical service industry. Executes product strategy, defines product vision and roadmaps, develops customer-driven product requirements incorporating human-centered design, drives product release cycles using Agile methodologies, and collaborates with cross-functional teams to deliver high quality solutions on time. Prior roles include IT Product Owner, IT Business Partner, Integrated Processes and Technologies POC Project/Product Manager, Predictive Analytics Lead SAS Developer, Biostatistics Senior SAS Statistical Programmer, Statistical Programming Manager, Clinical Data Programmer, and Associate Biostatistician.

      Session Details:

      Case Study: Optimizing clinical supply chain with advanced technology

      2024-09-17, 11:45 AM

      View In Agenda
      Next speaker
      Back
      Chris Varner
      Senior Director of Solutions Consulting, Endpoint Clinical

      Chris Varner is the Senior Director of Solutions Consulting at Endpoint Clinical, where he brings over 15 years of experience in the clinical trials industry. Joining the company in May 2024, Chris has over 8 years of expertise in site and clinical project management and more than 7 years in technology supporting clinical trials. He has successfully led a global team of 30+ project managers, focusing on designing and implementing DCT and eCOA solutions across various therapeutic areas and study phases. Throughout his career, Chris has developed effective operating models and cultivated strong relationships with major pharmaceutical companies, ensuring long-term delivery partnerships. His strong operational leadership is complemented by his collaboration with the sales team, where he helps ensure that proposals feature the most effective strategies at scale.

      Session Details:

      Unlocking the Future: Real-World AI Integration in IRT

      2024-09-17, 2:30 PM

      View In Agenda
      Next speaker
      Back
      Frank Leu
      CEO, BioPharMatrix
      Next speaker
      Back
      Mary Zhang
      National Account Manager, US Customs and Border Protection

      Mary Zhang – National Account Manager since 2009, at the Center of Excellence and Expertise for the Pharmaceuticals, Health and Chemicals (PHC-CEE) with U.S Customs and Border Protection (CBP). Ms. Zhang's previous experience includes serving as a Senior Import Specialist for the Trade Operations Division in the Port of New York/Newark, and Chicago. Previously she worked for the Revenue Management at the United Airlines.

      Next speaker
      Back
      Amy Mou
      Vendor Strategy Manager – FSP, Pfizer

      Session Details:

      Speaker Hosted Round Tables

      2024-09-18, 2:15 PM

      View In Agenda
      Next speaker
      Back
      Robbie Hill
      Director, Business Development, Mercalis

      Session Details:

      Aligning clinical supply strategies with sustainability goals

      2024-09-17, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Samit Bhatt
      Vice President, Clinical Trial Patient Solutions, Myonex

      Samit manages Myonex’s growing Clinical Trial Patient Solutions (CTPS) in North America and Europe. Samit and his team are responsible for the innovation and execution of CTPS to provide value to Myonex’s clients in addition to enhancing clinical trial sites and patient experience. He brings over 12 years’ experience in managing successful formulary status and relationship management with payers, a significant understanding of healthcare contracts, and knowledge of medical and pharmacy benefits including specialized knowledge across different therapeutic areas. Samit holds both a Doctor of Pharmacy degree and an MBA from Drake University.

      Session Details:

      Fostering patient centricity and diversity equity & inclusion with your supply chain decisions

      2024-09-17, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Jan Pieter Kappelle
      VP of Clinical Services at Inceptua

      Jan Pieter (JP) Kappelle, VP of Clinical Services at Inceptua, is a Supply Chain Executive with 30 years of industry experience, of which 15 years were spent leading clinical trial supplies departments in global pharmaceutical and biotech companies.

      Trained as an Electronic and Quality Engineer, JP has a strong financial background and brings a methodical, analytical and process-oriented approach to his work. Coupled with his MBA and MSc in Supply Chain Management, JP has the unique ability to switch between strategic and operational discussions.

      JP also serves as the Global Clinical Supplies Group (GCSG) Master of Ceremony where he connects clinical supply professionals for the purposes of education,
      knowledge sharing and the development of industry best practices.

       

      Next speaker
      Back
      Sascha Sonnenberg
      Vice President Global Business Development & Country Head Germany, SanaClis

      Sascha held numerous positions in business development and operations, most notably in global Commercial Operations AMERICAS & EMEA at Marken and VP Business Development at Sharp Clinical Services, where he formed a new business development team and implemented novel services. Sascha is a subject matter expert of a broad range of services along the clinical supply chain such as Direct-to-Patient, labelling & packaging, cell & gene therapies , and global distribution strategies. Sascha studied economics and holds a MBA in International Management and Leadership. He has been a long-term member of the ISPE Investigational Product community, contributed to the development of several Good Practice Guides and was a member of the European IP Steering Committee. At SanaClis Sascha is leading global business development and acts as Country Head Germany.

      Next speaker
      Back
      Sylvia Thomas
      Supervisory Consumer Safety Officer, Division of West Coast Import, FDA

      Session Details:

      Opening Keynote: FDA importation overview and how to resolve issues with import entries being held for examination

      2024-09-17, 8:30 AM

      View In Agenda
      Next speaker
      Back
      Fiona Barry
      Editor-in-Chief and Director of PharmSource, GlobalData

      Experienced healthcare editor with a demonstrated history of B2B journalism covering drug development, manufacturing, and the pharma industry. Skilled in editing, news writing, KOL interviews and financial journalism. Special focus on pharmaceutical manufacturing, clinical trials, rare disease and women's healthcare. Bilingual Glasgow/London-based English and French-speaking media professional with a Master of Arts (M.A.) in English from the University of Bristol.

      Session Details:

      Chair’s opening remarks

      2024-09-17, 8:25 AM

      Session Details:

      Chair’s opening remarks

      2024-09-18, 8:50 AM

      Session Details:

      Panel Discussion: Benchmarking success and assessing efficacy in avoiding dangerous pitfalls in clinical trial supply

      2024-09-18, 11:15 AM

      View In Agenda
      Next speaker
      Back
      Frank Leu
      CEO, Novapeutics,

      Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman, speaker, moderator, and facilitator for many life-sciences and drug development events.

      Next speaker

      Advisory Board

      Select a member to learn more

      Back
      Chris Wallace
      Head of Distribution EMEA, Argenx

      Chris has over 35 years’ varied supply chain experience, having worked for several blue chip companies in a number of industries including 3rd party logistics services, automotive, medical device, nuclear fuels and biotech/pharmaceuticals.

      Originally from the UK but now based in Switzerland, he has been involved in life science - biotech/pharmaceuticals & medical device - for over 20 years of his career and has latterly been SVP Global Supply Chain at Clover Biopharmaceutical before last year moving to Argenx as Head of Distribution EMEA.

      He has developed, implemented and managed global healthcare supply chain strategies and operations on 6 continents. This has included different set-ups in multiple countries, including many in the Emerging Markets as well as the developed world.

      Chris has a degree in economics from Manchester University, an MBA from Aston University and a postgraduate diploma from London University. In his spare time, he plays golf badly and loves to sample great Italian food and red wines!

      Next
      Back
      Luiz Barberini
      Head of External Manufacturing Latin America, Bayer
      • Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
        Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
      • Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
      • Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
      • Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
      • Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
      • Solid team management skills, as well as Customer Service relationship and management
      • Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

      CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

      Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

      Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

      Next
      Back
      Paul Hingst
      Supply Chain Consultant, Crinetics Pharmaceuticals

      Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

      Session Details:

      Closing Panel Discussion: Levelling up vendor partnerships so that both sides win

      2024-09-17, 5:00 PM

      View In Agenda
      Next
      Back
      Francesco Santo
      Associate Director Global Clinical Supply Chain, HUYABIO

      A highly experienced and passionate Clinical Supplies Project Manager, Francesco has dedicated the past 17 years to ensuring the seamless execution of clinical trials by optimizing supply chain operations. His deep commitment to this field is driven by a relentless pursuit of excellence in delivering life-saving treatments to patients worldwide.  Throughout his career, he has honed a diverse skill set, encompassing:

      • Strategic Supply Chain Management
      • Regulatory Compliance
      • Cross-Functional Collaboration
      • Risk Management
      • Innovative Problem-Solving

      Francesco’s dedication to the clinical supplies industry is rooted in a profound understanding of the critical role it plays in advancing medical research and improving patient outcomes. He is committed to continuing his journey in this field, always striving to contribute to the betterment of global health.

      Next
      Back
      Arnaud Dourlens
      Head of Clinical Trial Supply, Sanofi

      Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group. During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio. Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

      Next
      Back
      Paul Larochelle
      Director Global Clinical Supply Chain Planning, Takeda

      Paul Larochelle has over 17 years of experience in a variety of positions within Clinical Supplies, including roles in clinical planning, production scheduling and planning, secondary packaging operations management, and business expert for a clinical inventory management system. Paul currently leads a team of Clinical Planning Leads at Takeda and is a member of the Global Clinical Supply Chain (GCSC) Leadership Team. He also oversees Takeda’s GCSC Post-PharmD Fellowship Program in partnership with the Massachusetts College of Pharmacy and Health Sciences (MCPHS). Paul’s prior organizations include Genzyme/Sanofi and Biogen, supporting therapies across all indications and stages of development.

      In addition to his primary responsibilities, Paul served as a coordinator of Pharmacy Industry Fellowships for the Genzyme/Sanofi MCPHS Fellowship Program (2009-2014) and precepted over 50 pharmacy students interested in a career in industry for several schools. He is currently the Chair of the Dean’s Advisory Board for MCPHS Boston School of Pharmacy and a member of the Pharmacy Advisory Board for Western New England University. He is also a member of the Clinical Trial Supply Conference Series Advisory Board.

      Paul completed a Post-PharmD Industry Fellowship in Clinical Research/Investigational Product Management with Genzyme/MCPHS, a Doctorate in Pharmacy from MCPHS, an MBA from Worcester Polytechnic Institute, and a degree in Biology from Providence College. Paul has also served previously as President of the Board of Directors for the Massachusetts Pharmacists Association (MPhA), and as President of the MCPHS Alumni Association.

      Next

      Plan Your Visit

      Venue

      Hyatt Regency San Francisco Airport 1333 Bayshore Highway Burlingame California 94010 United States

      Book Your Stay

      Accommodation

      Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

      2024 Sponsors

      Select a sponsor to learn more

      Featured Sponsors

      Session sponsor

      Exhibitors

      Co-Sponsor

      Why partner?

       

      Contact us to become a partner

      Partnership Opportunities

      We work with you to design a bespoke package to meet your business needs, where you could:

      • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
      • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
        Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
      • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

      Event reach

      • 200+ attendees each year
      • 80% attendees C-suite level

       

      Take a look at our current sponsors

      Media Centre

      MEDIA PARTNERS

      Become A Media Partner

      A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

      Simply register, login on the day and get ready to connect and learn.

      The CTS West Coast is the meeting place for pharmaceutical and biotech experts to discuss key themes and opportunities to take control and optimize clinical supply chains.

      See What It's All About

      Enquiry

      Contact Us

      SPONSORSHIP ENQUIRIES

      Jaz Sidhu

      Senior Sponsorship Manager

      +44 (0) 207 9472755

      SPEAKING OPPORTUNITIES

      Ralitsa Pashkuleva

      Conference Producer

      MARKETING ENQUIRIES

      Moona Popal

      Marketing Manager

      +44 (0)20 7661 8812

      DELEGATE ENQUIRIES

      Sunny Saikia

      VIP Delegate Manager

      Sponsorship Enquiries

      To enquire about sponsorship opportunities for the conference, please contact:

       

      Jaz Sidhu

      Senior Sponsorship Manager


      +44 (0) 20 7947 2755

      Speaker Enquiries

      To enquire about speaking opportunities for the conference, please contact:

       

      Ralitsa Pashkuleva

      Conference Producer